NHL and Sjögren’s syndromeBCL2 (NHL) and IRF5 (Sjögren’s Syndrome) a potential cross-pathway interaction is suggested by the connection between BCL2’s role in apoptotic control in NHL and IRF5’s role in the immunological response in Sjögren’s syndrome. Here, BCL2 is linked to non-Hodgkin lymphoma.